Mallinckrodt

Mallinckrodt is a pharmaceutical company with a history dating back to 1867 when it was founded by Gustav Mallinckrodt in St. Louis, Missouri. Initially established as a pharmaceutical chemical manufacturer, the company expanded over time to produce various pharmaceutical products. Mallinckrodt is known for manufacturing generic drugs, specialty pharmaceuticals, and active pharmaceutical ingredients.

Throughout its existence, Mallinckrodt has undergone numerous transformations, including several acquisitions and divestitures. The company gained significant attention for its production of opioid medications, which subsequently led to legal challenges related to the ongoing opioid crisis in the United States. These legal matters have contributed to financial difficulties for the organization.

In recent years, Mallinckrodt has faced bankruptcy proceedings as part of efforts to address opioid litigation liabilities. The company has attempted to restructure its operations, focusing primarily on its specialty pharmaceuticals business while divesting certain assets. Mallinckrodt's evolution reflects the broader changes occurring within the pharmaceutical industry, particularly regarding regulatory pressures and shifting market demands for controlled substances and generic medications.